Q4 2015 Holdings
Filed 2016-02-10 | 7 holdings | $170.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2016-05-05) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Glaukos Corporation(GKOS)A | Common Stock | 377322102 | $77.6M | 3,136,232 | 45.4% |
| Five Prime Therapeutics, Inc.(FPRX) | Common Stock | 33830X104 | $45.3M | 1,092,152 | 26.5% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $20.8M | 2,215,384 | 12.1% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $14.3M | 407,416 | 8.3% |
| Achaogen, Inc. | Common Stock | 004449104 | $7.4M | 1,281,152 | 4.3% |
| Biotie Therapies Corp. | ADS | 09074D103 | $3.9M | 268,672 | 2.3% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $1.8M | 1,048,601 | 1.0% |